Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience

[1]  T. Buchholz,et al.  Radiotherapy following breast-conserving surgery for screen-detected ductal carcinoma in situ: indications and utilisation in the UK. Interim findings from the Sloane Project , 2008 .

[2]  M. Cooper,et al.  The significance of the Van Nuys prognostic index in the management of ductal carcinoma in situ , 2008, World journal of surgical oncology.

[3]  L. Holmberg,et al.  Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  G. Houvenaeghel,et al.  Sentinel Node Procedure is Warranted in Ductal Carcinoma In Situ with High Risk of Occult Invasive Carcinoma and Microinvasive Carcinoma Treated by Mastectomy , 2008, The breast journal.

[5]  A. Weill,et al.  Baisse de l’incidence des cancers du sein en 2005 et 2006 en France : un phénomène paradoxal , 2008 .

[6]  A. Weill,et al.  [Decline in breast cancer incidence in 2005 and 2006 in France: a paradoxical trend]. , 2008, Bulletin du cancer.

[7]  P. Horn-Ross,et al.  Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast , 2008, Breast Cancer Research and Treatment.

[8]  D. Santini,et al.  259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up , 2008, Breast Cancer Research and Treatment.

[9]  D. Wazer,et al.  An attempt to independently verify the utility of the Van Nuys Prognostic Index for ductal carcinoma in situ , 2007, Cancer.

[10]  T. Wobbes,et al.  Local recurrences after different treatment strategies for ductal carcinoma in situ of the breast: a population-based study in the East Netherlands. , 2007, International journal of radiation oncology, biology, physics.

[11]  J. Dewar,et al.  Radiotherapy following breast-conserving surgery for screen-detected ductal carcinoma in situ: indications and utilisation in the UK. Interim findings from the Sloane Project , 2007, British Journal of Cancer.

[12]  E. Kliewer,et al.  A decline in breast-cancer incidence. , 2007, The New England journal of medicine.

[13]  J. Peterse,et al.  Clinical Outcome after Selective Treatment of Patients Diagnosed with Ductal Carcinoma In Situ of the Breast , 2007, Annals of Surgical Oncology.

[14]  G. Elfenbein.  A decline in breast-cancer incidence. , 2007, The New England journal of medicine.

[15]  E. Rakovitch,et al.  The management of ductal carcinoma in situ of the breast: a screened population-based analysis , 2007, Breast Cancer Research and Treatment.

[16]  K. Mokbel,et al.  Heterogeneity of ductal carcinoma in situ and its effects on management. , 2006, The Lancet. Oncology.

[17]  M. Silverstein,et al.  Prospective study of wide excision alone for ductal carcinoma in situ of the breast. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  Benjamin D. Smith,et al.  Rationalization and regionalization of treatment for ductal carcinoma in situ of the breast. , 2006, International journal of radiation oncology, biology, physics.

[19]  M. Amichetti,et al.  Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network. , 2006, The Lancet. Oncology.

[20]  J. Peterse,et al.  Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  B. Grosbois,et al.  Superiority of melphalan-prednisone (MP) + thalidomide (THAL) over MP and autologous stem cell transplantation in the treatment of newly diagnosed elderly patients with multiple myeloma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  L. Solin.  Is excision alone adequate treatment for low-risk ductal carcinoma-in-situ of the breast? , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  L. Holmberg,et al.  SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening , 2006, Acta oncologica.

[24]  M. Kerin,et al.  The role of sentinel lymph node biopsy in ductal carcinoma in situ. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[25]  C. Key,et al.  The frequency of ipsilateral second tumors after breast‐conserving surgery for DCIS , 2005, Cancer.

[26]  M. Morrow,et al.  An adequate margin of excision in ductal carcinoma in situ , 2005, BMJ : British Medical Journal.

[27]  H. Macdonald,et al.  Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins. , 2005, American journal of surgery.

[28]  A. Fagerlin,et al.  Patterns and correlates of local therapy for women with ductal carcinoma-in-situ. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  M. Dilhuydy,et al.  Mammography of ductal carcinoma in situ of the breast: review of 909 cases with radiographic-pathologic correlations. , 2005, European journal of radiology.

[30]  H. Bartelink,et al.  Long‐term outcome after breast‐conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast , 2005, Cancer.

[31]  L. Mauriac,et al.  [Standards, Options and Recommendations for the management of ductal carcinoma in situ of the breast (DCIS): update 2004]. , 2005, Bulletin du cancer.

[32]  P. Cottu,et al.  A French national survey on infiltrating breast cancer: analysis of clinico-pathological features and treatment modalities in 1159 patients , 2005, Breast Cancer Research and Treatment.

[33]  Christof Schäfer,et al.  Waiting for Radiotherapy , 2005, Strahlentherapie und Onkologie.

[34]  R. Jagsi,et al.  The management of ductal carcinoma in situ in North America and Europe , 2004, Cancer.

[35]  S. Swain,et al.  Ductal carcinoma in situ, complexities and challenges. , 2004, Journal of the National Cancer Institute.

[36]  J. Palazzo,et al.  The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast , 2004, Cancer.

[37]  T. Tuttle,et al.  Trends in the treatment of ductal carcinoma in situ of the breast. , 2004, Journal of the National Cancer Institute.

[38]  S. Singletary,et al.  Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ , 2004, Cancer.

[39]  J. Houghton.  Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomized controlled trial , 2003, The Lancet.

[40]  N. Bundred,et al.  Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast‐conserving surgery , 2003, The British journal of surgery.

[41]  A. Hart,et al.  Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCIS , 2002, British Journal of Cancer.

[42]  S. Singletary,et al.  Standard for the Management of Ductal Carcinoma In Situ of the Breast (DCIS) , 2002, CA: a cancer journal for clinicians.

[43]  C. Lemanski,et al.  Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers' experience. , 2002, International journal of radiation oncology, biology, physics.

[44]  K. McMasters,et al.  Sentinel lymph node biopsy in patients with ductal carcinoma in situ , 2002, Cancer.

[45]  F. Vicini,et al.  Age at diagnosis and outcome for women with ductal carcinoma-in-situ of the breast: a critical review of the literature. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  I. Barillot,et al.  Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. , 2001, The New England journal of medicine.

[47]  N. Wolmark,et al.  Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. , 2001, Seminars in oncology.

[48]  D. Schultz,et al.  Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status. , 2001, International journal of radiation oncology, biology, physics.

[49]  L Duchateau,et al.  Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[50]  E. Rutgers,et al.  Quality control in the locoregional treatment of breast cancer. , 2001, European journal of cancer.

[51]  K. Kerlikowske,et al.  Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. , 2000, Archives of internal medicine.

[52]  G. Schwartz,et al.  Consensus Conference on the Classification of Ductal Carcinoma of the Breast, April 22–25, 1999 , 2000, The breast journal.

[53]  G. Schwartz,et al.  [The consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999]. , 2000, Bulletin du cancer.

[54]  G. Schwartz,et al.  Consensus Conference on the Treatment of In Situ Ductal Carcinoma of the Breast, April 22-25, 1999. , 2000, Cancer.

[55]  James Dignam,et al.  Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial , 1999, The Lancet.

[56]  S. Martino,et al.  The influence of margin width on local control of ductal carcinoma in situ of the breast. , 1999, The New England journal of medicine.

[57]  S. Martino,et al.  Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[58]  M. Silverstein,et al.  A prognostic index for ductal carcinoma in situ of the breast , 1996, Cancer.

[59]  A POMBAL,et al.  [Results of a survey]. , 1955, Jornal do medico.